Level 2: Viral research
Version 1.142
|
review
|
BOTH monoallelic and biallelic, autosomal or pseudoautosomal
|
Sources
- IUIS Classification December 2031
- IUIS Classification February 2018
- A- or hypo-gammaglobulinaemia v1.25
- London North GLH
- NHS GMS
- Victorian Clinical Genetics Services
- North West GLH
- ESID Registry 20171117
- Expert Review Green
- NHS GMS
- North West GLH
- London North GLH
- Expert Review Green
- IUIS Classification February 2018
- Victorian Clinical Genetics Services
- ESID Registry 20171117
- A- or hypo-gammaglobulinaemia v1.25
Phenotypes
- Agammaglobulinemia 8A, autosomal dominant, OMIM:616941
- Agammaglobulinemia 8B, autosomal recessive, OMIM:619824
- Recurrent bacterial infections
- Predominantly Antibody Deficiencies
|
Version 4.202
Latest signed off version: v4.0
(22 Mar 2023)
|
review
|
BOTH monoallelic and biallelic, autosomal or pseudoautosomal
|
Sources
- NHS GMS
- North West GLH
- London North GLH
- Expert Review Green
- IUIS Classification February 2018
- Victorian Clinical Genetics Services
- ESID Registry 20171117
- A- or hypo-gammaglobulinaemia v1.25
Phenotypes
- Agammaglobulinemia 8A, autosomal dominant, OMIM:616941
- Agammaglobulinemia 8B, autosomal recessive, OMIM:619824
- Recurrent bacterial infections
- Predominantly Antibody Deficiencies
|
Level 3: Pertinent cancer susceptibility gene panel
Level 2: Cancer Programme
Version 4.4
Latest signed off version: v4.0
(22 Mar 2023)
|
review
|
BOTH monoallelic and biallelic, autosomal or pseudoautosomal
|
Sources
Phenotypes
- B-cell acute lymphoblastic leukemia
|
Version 1.184
|
review
|
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
|
Sources
- Next Generation Children Project
- Expert Review Green
- Expert list
Phenotypes
- Agammaglobulinemia 8, autosomal dominant, 616941
|